{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T03:18:07Z","timestamp":1775531887422,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>When it was first introduced in 2000, reverse vaccinology was defined as an in silico approach that begins with the pathogen's genomic sequence. It concludes with a list of potential proteins with a possible, but not necessarily, list of peptide candidates that need to be experimentally confirmed for vaccine production. During the subsequent years, reverse vaccinology has dramatically changed: now it consists of a large number of bioinformatics tools and processes, namely subtractive proteomics, computational vaccinology, immunoinformatics, and in silico related procedures. However, the state of the art of reverse vaccinology still misses the ability to predict the efficacy of the proposed vaccine formulation. Here, we describe how to fill the gap by introducing an advanced immune system simulator that tests the efficacy of a vaccine formulation against the disease for which it has been designed. As a working example, we entirely apply this advanced reverse vaccinology approach to design and predict the efficacy of a potential vaccine formulation against influenza H5N1. Climate change and melting glaciers are critical due to reactivating frozen viruses and emerging new pandemics. H5N1 is one of the potential strains present in icy lakes that can raise a pandemic. Investigating structural antigen protein is the most profitable therapeutic pipeline to generate an effective vaccine against H5N1. In particular, we designed a multi-epitope vaccine based on predicted epitopes of hemagglutinin and neuraminidase proteins that potentially trigger B-cells, CD4, and CD8 T-cell immune responses. Antigenicity and toxicity of all predicted CTL, Helper T-lymphocytes, and B-cells epitopes were evaluated, and both antigenic and non-allergenic epitopes were selected. From the perspective of advanced reverse vaccinology, the Universal Immune System Simulator, an in silico trial computational framework, was applied to estimate vaccine efficacy using a cohort of 100 digital patients.\n<\/jats:p>","DOI":"10.1186\/s12859-023-05374-1","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:09:12Z","timestamp":1685934552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza"],"prefix":"10.1186","volume":"24","author":[{"given":"Giulia","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Crispino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avisa","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Di Salvatore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Stanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"5374_CR1","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3389\/fimmu.2019.02776","volume":"10","author":"R Moxon","year":"2019","unstructured":"Moxon R, Reche PA, Rappuoli R. Editorial: reverse vaccinology. Front Immunol. 2019;10:2776.","journal-title":"Front Immunol"},{"key":"5374_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1359-6446(03)02689-8","volume":"8","author":"M Mora","year":"2003","unstructured":"Mora M, Veggi D, Santini L, Pizza M, Rappuoli R. Reverse vaccinology. Drug Discov Today. 2003;8:459\u201364.","journal-title":"Drug Discov Today"},{"key":"5374_CR3","doi-asserted-by":"publisher","DOI":"10.1515\/9781400880188","volume-title":"Life in ancient ice","author":"JD Castello","year":"2005","unstructured":"Castello JD, Rogers SO. Life in ancient ice. Princeton University Press; 2005."},{"key":"5374_CR4","doi-asserted-by":"publisher","unstructured":"Castello JD, Rogers SO, Starmer W, et al. Detection of tomato mosaic tobamovirus RNA in ancient glacial ice. Polar Biol 1999;22:207\u2013212. https:\/\/doi.org\/10.1007\/s003000050411.","DOI":"10.1007\/s003000050411"},{"key":"5374_CR5","doi-asserted-by":"publisher","first-page":"12229","DOI":"10.1128\/JVI.00986-06","volume":"80","author":"G Zhang","year":"2006","unstructured":"Zhang G, Shoham D, Gilichinsky D, Davydov S, Castello JD, Rogers SO. Evidence of influenza A virus RNA in Siberian Lake ice. J Virol. 2006;80:12229\u201335.","journal-title":"J Virol"},{"key":"5374_CR6","first-page":"265","volume":"1","author":"SS Abyzov","year":"1993","unstructured":"Abyzov SS. Microorganisms in the Antarctic ice. Antarct Microbiol. 1993;1:265\u201396.","journal-title":"Antarct Microbiol"},{"key":"5374_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1029\/AR059p0165","volume":"59","author":"GM Simmons Jr","year":"1993","unstructured":"Simmons GM Jr, Vestal JR, Wharton RA Jr. Environmental regulators of microbial activity in continental Antarctic lakes. Phys Biogeochem Process Antarct Lakes. 1993;59:165\u201395.","journal-title":"Phys Biogeochem Process Antarct Lakes"},{"key":"5374_CR8","first-page":"234","volume":"26","author":"C Catranis","year":"1991","unstructured":"Catranis C. Microorganisms entrapped in glacial ice. Antarct J US. 1991;26:234\u20136.","journal-title":"Antarct J US"},{"key":"5374_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.mehy.2004.04.004","volume":"63","author":"SO Rogers","year":"2004","unstructured":"Rogers SO, Starmer WT, Castello JD. Recycling of pathogenic microbes through survival in ice. Med Hypotheses. 2004;63:773\u20137.","journal-title":"Med Hypotheses"},{"key":"5374_CR10","unstructured":"Parker Lv, Martel CJ. Long-term survival of enteric microorganisms in frozen wastewater. 2002."},{"key":"5374_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1128\/CMR.14.1.129-149.2001","volume":"14","author":"T Horimoto","year":"2001","unstructured":"Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev. 2001;14:129\u201349.","journal-title":"Clin Microbiol Rev"},{"key":"5374_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1128\/mr.56.1.152-179.1992","volume":"56","author":"RG Webster","year":"1992","unstructured":"Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152\u201379.","journal-title":"Microbiol Rev"},{"key":"5374_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.7774\/cevr.2014.3.2.117","volume":"3","author":"TH Le","year":"2014","unstructured":"Le TH, Nguyen NTB. Evolutionary dynamics of highly pathogenic avian influenza A\/H5N1 HA clades and vaccine implementation in Vietnam. Clin Exp Vaccine Res. 2014;3:117\u201327.","journal-title":"Clin Exp Vaccine Res"},{"key":"5374_CR14","first-page":"227","volume":"333","author":"MJ Sylte","year":"2009","unstructured":"Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol. 2009;333:227\u201341.","journal-title":"Curr Top Microbiol Immunol"},{"key":"5374_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tim.2018.03.005","volume":"26","author":"CJ Russell","year":"2018","unstructured":"Russell CJ, Hu M, Okda FA. Influenza hemagglutinin protein stability, activation, and pandemic risk. Trends Microbiol. 2018;26:841\u201353.","journal-title":"Trends Microbiol"},{"key":"5374_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbab403","volume":"23","author":"G Russo","year":"2022","unstructured":"Russo G, di Salvatore V, Sgroi G, Parasiliti Palumbo GA, Reche PA, Pappalardo F. A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets. Brief Bioinform. 2022;23:1\u20139.","journal-title":"Brief Bioinform"},{"key":"5374_CR17","doi-asserted-by":"publisher","unstructured":"Pappalardo F, Russo G, Tshinanu FM, Viceconti M. In silico clinical trials: concepts and early adoptions. https:\/\/doi.org\/10.1093\/bib\/bby043.","DOI":"10.1093\/bib\/bby043"},{"key":"5374_CR18","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.1158\/0008-5472.CAN-10-0701","volume":"70","author":"A Palladini","year":"2010","unstructured":"Palladini A, Nicoletti G, Pappalardo F, Murgo A, Grosso V, Stivani V, et al. In silico modeling and in vivo efficacy of cancer-preventive vaccinations. Cancer Res. 2010;70:7755\u201363.","journal-title":"Cancer Res"},{"key":"5374_CR19","doi-asserted-by":"publisher","unstructured":"Papparlardo F, Russo G, Pennisi M, Palumbo GAP, Sgroi G, Motta S, et al. The potential of computational modeling to predict disease course and treatment response in patients with relapsing multiple sclerosis. 2020. https:\/\/doi.org\/10.20944\/PREPRINTS202001.0174.V1.","DOI":"10.20944\/PREPRINTS202001.0174.V1"},{"key":"5374_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-019-3045-5","volume":"20","author":"M Pennisi","year":"2019","unstructured":"Pennisi M, Russo G, Sgroi G, Bonaccorso A, Parasiliti Palumbo GA, Fichera E, et al. Predicting the artificial immunity induced by RUTI\u00ae vaccine against tuberculosis using universal immune system simulator (UISS). BMC Bioinf. 2019;20:1\u201310.","journal-title":"BMC Bioinf"},{"key":"5374_CR21","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.csbj.2022.03.024","volume":"20","author":"F Pappalardo","year":"2022","unstructured":"Pappalardo F, Russo G, Corsini E, Paini A, Worth A. Translatability and transferability of in silico models: context of use switching to predict the effects of environmental chemicals on the immune system. Comput Struct Biotechnol J. 2022;20:1764\u201377.","journal-title":"Comput Struct Biotechnol J"},{"key":"5374_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-020-03872-0","volume":"21","author":"G Russo","year":"2020","unstructured":"Russo G, Pennisi M, Fichera E, Motta S, Raciti G, Viceconti M, et al. In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform. BMC Bioinf. 2020;21:1\u201316.","journal-title":"BMC Bioinf"},{"key":"5374_CR23","doi-asserted-by":"publisher","first-page":"e26523","DOI":"10.1371\/journal.pone.0026523","volume":"6","author":"F Pappalardo","year":"2011","unstructured":"Pappalardo F, Forero IM, Pennisi M, Palazon A, Melero I, Motta S. SimB16: modeling induced immune system response against B16-melanoma. PLoS ONE. 2011;6:e26523.","journal-title":"PLoS ONE"},{"key":"5374_CR24","doi-asserted-by":"crossref","unstructured":"Sun B, Zhang J, Li Z, Xie M, Luo C, Wang Y, et al. Integration: gospel for immune bioinformatician on epitope-based therapy. Front Immunol. 2023;14.","DOI":"10.3389\/fimmu.2023.1075419"},{"key":"5374_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539.","journal-title":"Mol Syst Biol"},{"key":"5374_CR26","doi-asserted-by":"crossref","unstructured":"Procter JB, Carstairs GM, Soares B, Mour\u00e3o K, Ofoegbu TC, Barton D, et al. Alignment of biological sequences with Jalview. In: Methods in molecular biology. Humana Press Inc.; 2021. p 203\u201324.","DOI":"10.1007\/978-1-0716-1036-7_13"},{"key":"5374_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-7-1","volume":"7","author":"Z Stanekov","year":"2010","unstructured":"Stanekov Z, Varekov E. Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J. 2010;7:1\u201313.","journal-title":"Virol J"},{"key":"5374_CR28","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","volume":"19","author":"B Reynisson","year":"2020","unstructured":"Reynisson B, Barra C, Kaabinejadian S, Hildebrand WH, Peters B, Nielsen M. Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data. J Proteome Res. 2020;19:2304.","journal-title":"J Proteome Res"},{"key":"5374_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1536867X20909688","volume":"20","author":"M Schonlau","year":"2020","unstructured":"Schonlau M, Zou RY. The random forest algorithm for statistical learning. Stata Journal. 2020;20:3\u201329.","journal-title":"Stata Journal"},{"key":"5374_CR30","doi-asserted-by":"crossref","unstructured":"Zhang J, Tao A, Tao A, Raz E, Bioinformatics A, bioinformatics T. Antigen Immunogen Allergen. 2015;175\u201386.","DOI":"10.1007\/978-94-017-7444-4_11"},{"key":"5374_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov I, Bangov I, Flower DR, Doytchinova I. AllerTOP vol 2\u2013a server for in silico prediction of allergens. J Mol Model. 2014;20:1\u20136.","journal-title":"J Mol Model"},{"key":"5374_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-020-03776-z","volume":"21","author":"MA Ju\u00e1rez","year":"2020","unstructured":"Ju\u00e1rez MA, Pennisi M, Russo G, Kiagias D, Curreli C, Viceconti M, et al. Generation of digital patients for the simulation of tuberculosis with UISS-TB. BMC Bioinf. 2020;21:1\u20138.","journal-title":"BMC Bioinf"},{"issue":"Suppl","key":"5374_CR33","first-page":"17","volume":"21","author":"G Russo","year":"2020","unstructured":"Russo G, Pennisi M, Fichera E, Motta S, Raciti G, Viceconti M, et al. In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform. BMC Bioinf. 2020;21(Suppl):17.","journal-title":"BMC Bioinf"},{"key":"5374_CR34","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1128\/JVI.01623-05","volume":"80","author":"P Baccam","year":"2006","unstructured":"Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A Virus infection in humans. J Virol. 2006;80:7590\u20139.","journal-title":"J Virol"},{"key":"5374_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.1998.tb08316.x","volume":"856","author":"G Luheshi","year":"1998","unstructured":"Luheshi G. Cytokines and fever: mechanisms and sites of action. Ann N Y Acad Sci. 1998;856:83\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"5374_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s43588-022-00198-0","volume":"2","author":"P Padmanabhan","year":"2022","unstructured":"Padmanabhan P, Desikan R, Dixit NM. Modeling how antibody responses may determine the efficacy of COVID-19 vaccines. Nat Comput Sci. 2022;2:123\u201331.","journal-title":"Nat Comput Sci"},{"key":"5374_CR37","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, Gilbert PB, Siber GR, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39:4423\u20138.","journal-title":"Vaccine"},{"key":"5374_CR38","doi-asserted-by":"publisher","unstructured":"Klomp M, Ghosh S, Mohammed S, Khan MN. From virus to inflammation, how influenza promotes lung damage. https:\/\/doi.org\/10.1002\/JLB.4RU0820-232R.","DOI":"10.1002\/JLB.4RU0820-232R"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-023-05374-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-023-05374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:09:23Z","timestamp":1685934563000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-023-05374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5374"],"URL":"https:\/\/doi.org\/10.1186\/s12859-023-05374-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}